4//SEC Filing
Hardy Nathan 4
Accession 0001562180-23-007547
CIK 0001770121other
Filed
Nov 2, 8:00 PM ET
Accepted
Nov 3, 4:07 PM ET
Size
5.8 KB
Accession
0001562180-23-007547
Insider Transaction Report
Form 4
Hardy Nathan
SVP, Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2023-11-02+10,000→ 10,000 total→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. ("Sana") common stock.
- [F2]The restricted stock units will vest in full on January 2, 2025, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through such date.
Documents
Issuer
Sana Biotechnology, Inc.
CIK 0001770121
Entity typeother
Related Parties
1- filerCIK 0001830053
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 8:00 PM ET
- Accepted
- Nov 3, 4:07 PM ET
- Size
- 5.8 KB